Resumen

AMARU, Ricardo et al. HIGH DOSES OF COBALAMIN AND FOLIC ACID IN POST-COVID-19 LEUKOPENIA TREATMENT. Rev. Méd. La Paz [online]. 2021, vol.27, n.1, pp.9-14. ISSN 1726-8958.

Introduction: Leukopenia is one of the persistent manifestations in patients who have suffered from COVID-19 and its characteristics are similar to those patients with vitamin B12 and folic acid deficiency. Objective: To show the usefulness high doses of vitamin B12 and folic acid in post COVID-19 leukopenia treatment. Material and methods: Retrospective descriptive cross-sectional study. Demographic, clinical and laboratory data were collected from patients (n = 22) with post COVID-19 leukopenia who were treated with doses of vitamin B12 and folic acid. Follow-up of clinical and laboratory data corresponding to diagnosis as well as 4 and 8 weeks after treatment was assessed. Results: Leukopenia was totally reversed, leukocytes increased and reached normal values. Hemoglobin levels increased, although without reaching normal values. Lymphocytes increased within normal parameters though they were not decreased at diagnosis. MCV levels remained with slight modifications, and platelets without modifications. Patients symptoms subsided after 2 months treatment. Conclusion: Data obtained can serve as part of treatment rationale in post-COVID-19 syndrome.

Palabras clave : COVID-19; SARS-CoV-2; leukopenia; vitamin B12; folic acid.

        · resumen en Español     · texto en Español     · Español ( pdf )